Envista (NYSE:NVST) Issues Earnings Results

Envista (NYSE:NVST) posted its earnings results on Wednesday. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.03, Briefing.com reports. The company had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The company’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.43 EPS.

Envista Stock Up 9.7 %

Shares of NVST stock traded up $1.86 during trading on Thursday, reaching $21.09. The company’s stock had a trading volume of 4,976,399 shares, compared to its average volume of 2,427,292. The company has a market cap of $3.63 billion, a price-to-earnings ratio of -2.76 and a beta of 1.32. Envista has a one year low of $15.15 and a one year high of $25.64. The business has a fifty day moving average price of $18.54 and a 200-day moving average price of $18.04. The company has a quick ratio of 1.90, a current ratio of 2.22 and a debt-to-equity ratio of 0.47.

Insider Buying and Selling at Envista

In related news, CFO Eric D. Hammes bought 24,532 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average price of $16.33 per share, for a total transaction of $400,607.56. Following the completion of the acquisition, the chief financial officer now owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

NVST has been the subject of a number of analyst reports. JPMorgan Chase & Co. cut shares of Envista from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Robert W. Baird boosted their price target on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and raised their price objective for the stock from $16.00 to $23.00 in a research note on Thursday. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research note on Thursday. Finally, Stifel Nicolaus raised their price target on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.71.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.